Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 31, Number 4—April 2025
Synopsis
Maternal and Fetal Implications of Oropouche Fever, Espírito Santo State, Brazil, 2024
Table 1
Demographic and clinical characteristics of 73 pregnant women with Oropouche virus infection in Espírito Santo State, Brazil, March 28–December 22, 2024*
Characteristic | Pregnancy ongoing, n = 58 | Pregnancy concluded, n = 15 | Total |
---|---|---|---|
Age, y | |||
Median (IQR) | 29 (24–34) | 28 (25–31) | 29 (24–33) |
Mean (+SD) | 28.70 (5.73) | 28.73 (4.84) | 28.71 (5.52) |
18–19 | 4 (6.90) | 0 | 4 (5.48) |
20–29 | 26 (44.83) | 9 (60.00) | 35 (47.95) |
30–39 | 27 (46.55) | 5 (33.33) | 32 (43.84) |
40–42 |
1 (1.72) |
1 (6.67) |
2 (2.74) |
Underlying condition | |||
Hypertension | 6 (10.34) | NA | 6 (8.22) |
Diabetes |
1 (1.72) |
NA |
1 (1.37) |
Pregnancy trimester during Oropouche fever | |||
First | 12 (20.69) | 2 (13.33) | 14 (19.18) |
Second | 26 (44.83) | NA | 26 (35.62) |
Third |
20 (34.48) |
13 (86.67) |
33 (45.21) |
Oropouche fever clinical manifestation | |||
Fever | 42 (72.41) | 13 (86.67) | 55 (75.34) |
Headache | 46 (79.31) | 13 (86.67) | 59 (80.82) |
Myalgia | 41 (70.69) | 11 (73.33) | 52 (71.23) |
Back pain | 23 (39.66) | 5 (33.33) | 28 (38.36) |
Arthralgia | 8 (13.79) | 2 (13.33) | 10 (13.70) |
Retro-ocular pain | 27 (46.55) | 5 (33.33) | 32 (43.84) |
Nausea | 23 (39.66) | 6 (40.00) | 29 (39.73) |
Vomiting | 11 (18.97) | NA | 11 (15.07) |
Petechia | 4 (6.90) | 1 (6.67) | 5 (6.85) |
Exanthema | 9 (15.52) | 2 (13.33) | 11 (15.07) |
*Values are no. (%) except as indicated. IQR, interquartile range; NA, not applicable.
1These first authors contributed equally to this article.
2These senior authors contributed equally to this article.
Page created: February 05, 2025
Page updated: February 24, 2025
Page reviewed: February 24, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.